Study of heart valve replacement outcomes in Chinese patients
Part of Heart & circulation clinical trials.
This study records results of a minimally invasive procedure to replace a narrowed or leaking heart valve. It may help doctors understand how well the treatment works and what complications happen in Chinese patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptoms from aortic stenosis or aortic regurgitation (a narrowed or leaky aortic heart valve).
- You can understand the study and choose to sign consent in writing.
- You agree to come back for follow-up visits and return to the hospital where the procedure was done.
- Your heart and blood vessels are suitable for the transcatheter (catheter-based) valve procedure.
- You can’t have certain medication or material allergies that cannot be treated with pre-medicine.
- You agree to receive blood transfusions if needed, and you have at least a one-year expected survival.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks patients getting a new heart valve (transcatheter aortic valve implantation) for severe aortic stenosis. It aims to understand long-term outcomes and safety in a real-world registry.
This study follows adults who are having aortic valve replacement (through surgery or a catheter) to see how often certain outcomes happen after the procedure. You may be asked for blood tests and scans at set times, and some people may also be offered a special CT scan.
This trial is testing a new, less invasive way to replace a narrowed aortic valve using a special device. The goal is to help improve blood flow and reduce symptoms like chest pain and shortness of breath.
This study looks for biological markers in the blood that might help predict heart-related events in people with a narrowed aortic heart valve. It aims to improve care for those with this condition, whether or not they have a procedure called TAVI to replace the valve.
This trial tests a new valve device placed through a small tube (catheter) to treat severe aortic stenosis, a condition where the aortic valve is narrowed and doesn't open fully. It's for patients who cannot have traditional open-heart surgery.
This study tests whether a computer program helps doctors place a new heart valve more accurately during a minimally invasive procedure for severe aortic stenosis. The goal is to make the valve placement safer and more effective for patients like you.
Hear when a new Symptomatic Aortic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.